SHYFT Analytics and PAREXEL International on Thursday, Nov. 8, announced a partnership that makes SHYFT’s technology “an integral part” of PAREXEL’s real-world evidence research for both biopharma and medical device clients, according to a press release.
The partnership looks to fuse PAREXEL’s scientific and clinical resources with SHYFT’s suite of RWE solutions to “provide insights and outcomes for patient-level data more efficiently to customers worldwide.”
“PAREXEL is, and always has been, committed to helping sponsor organizations navigate the complexities of drug development,” PAREXEL Chief Data Officer Michelle Hoiseth said in a statement. “The growing availability of real-world data combined with innovative analytics methods and groundbreaking technologies present an opportunity to assist our organization in delivering on that commitment.”
SHYFT and PAREXEL will be at booth 211 at the Nov. 10-14 ISPOR Europe 2018 conference in Barcelona, Spain, according to the release.
To read the full press release, click here.